Literature DB >> 24619276

Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study.

Campbell J Le Heron1, Sarah L Wright1, Tracy R Melzer2, Daniel J Myall1, Michael R MacAskill2, Leslie Livingston2, Ross J Keenan3, Richard Watts4, John C Dalrymple-Alford5, Tim J Anderson6.   

Abstract

Emerging evidence suggests that Alzheimer's disease (AD) and Parkinson's disease dementia (PDD) share neurodegenerative mechanisms. We sought to directly compare cerebral perfusion in these two conditions using arterial spin labeling magnetic resonance imaging (ASL-MRI). In total, 17 AD, 20 PDD, and 37 matched healthy controls completed ASL and structural MRI, and comprehensive neuropsychological testing. Alzheimer's disease and PDD perfusion was analyzed by whole-brain voxel-based analysis (to assess absolute blood flow), a priori specified region of interest analysis, and principal component analysis (to generate a network differentiating the two groups). Corrections were made for cerebral atrophy, age, sex, education, and MRI scanner software version. Analysis of absolute blood flow showed no significant differences between AD and PDD. Comparing each group with controls revealed an overlapping, posterior pattern of hypoperfusion, including posterior cingulate gyrus, precuneus, and occipital regions. The perfusion network that differentiated AD and PDD groups identified relative differences in medial temporal lobes (AD<PDD) and right frontal cortex (PDD<AD). In conclusion, the pattern of cerebral hypoperfusion is very similar in AD and PDD. This suggests closely linked mechanisms of neurodegeneration mediating the evolution of dementia in both conditions.

Entities:  

Mesh:

Year:  2014        PMID: 24619276      PMCID: PMC4050238          DOI: 10.1038/jcbfm.2014.40

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  34 in total

1.  Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

Authors:  Stephen M Smith; Thomas E Nichols
Journal:  Neuroimage       Date:  2008-04-11       Impact factor: 6.556

Review 2.  Applications of arterial spin labeled MRI in the brain.

Authors:  John A Detre; Hengyi Rao; Danny J J Wang; Yu Fen Chen; Ze Wang
Journal:  J Magn Reson Imaging       Date:  2012-01-13       Impact factor: 4.813

3.  Cognitive profile of patients with newly diagnosed Parkinson disease.

Authors:  Dino Muslimovic; Bart Post; Johannes D Speelman; Ben Schmand
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

4.  Initiation and synergistic fibrillization of tau and alpha-synuclein.

Authors:  Benoit I Giasson; Mark S Forman; Makoto Higuchi; Lawrence I Golbe; Charles L Graves; Paul T Kotzbauer; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2003-04-25       Impact factor: 47.728

5.  Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease.

Authors:  Y Chen; D A Wolk; J S Reddin; M Korczykowski; P M Martinez; E S Musiek; A B Newberg; P Julin; S E Arnold; J H Greenberg; J A Detre
Journal:  Neurology       Date:  2011-11-16       Impact factor: 9.910

6.  β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.

Authors:  Hitoshi Shimada; Hitoshi Shinotoh; Shigeki Hirano; Michie Miyoshi; Koichi Sato; Noriko Tanaka; Tsuneyoshi Ota; Kiyoshi Fukushi; Toshiaki Irie; Hiroshi Ito; Makoto Higuchi; Satoshi Kuwabara; Tetsuya Suhara
Journal:  Mov Disord       Date:  2012-12-05       Impact factor: 10.338

7.  Parkinson disease with dementia: comparing patients with and without Alzheimer pathology.

Authors:  Marwan N Sabbagh; Charles H Adler; Tyson J Lahti; Donald J Connor; Linda Vedders; Lars K Peterson; John N Caviness; Holly A Shill; Lucia I Sue; Iryna Ziabreva; Elaine Perry; Clive G Ballard; Dag Aarsland; Douglas G Walker; Thomas G Beach
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jul-Sep       Impact factor: 2.703

8.  The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years.

Authors:  Mariese A Hely; Wayne G J Reid; Michael A Adena; Glenda M Halliday; John G L Morris
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

9.  Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

Authors:  Yaroslau Compta; Laura Parkkinen; Sean S O'Sullivan; Jana Vandrovcova; Janice L Holton; Catherine Collins; Tammaryn Lashley; Constantinos Kallis; David R Williams; Rohan de Silva; Andrew J Lees; Tamas Revesz
Journal:  Brain       Date:  2011-05       Impact factor: 13.501

Review 10.  Clinical diagnostic criteria for dementia associated with Parkinson's disease.

Authors:  Murat Emre; Dag Aarsland; Richard Brown; David J Burn; Charles Duyckaerts; Yoshikino Mizuno; Gerald Anthony Broe; Jeffrey Cummings; Dennis W Dickson; Serge Gauthier; Jennifer Goldman; Christopher Goetz; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Ian McKeith; Warren Olanow; Werner Poewe; Niall Quinn; Christina Sampaio; Eduardo Tolosa; Bruno Dubois
Journal:  Mov Disord       Date:  2007-09-15       Impact factor: 10.338

View more
  28 in total

Review 1.  Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.

Authors:  Christina E Wierenga; Chelsea C Hays; Zvinka Z Zlatar
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

2.  The cerebral blood flow deficits in Parkinson's disease with mild cognitive impairment using arterial spin labeling MRI.

Authors:  Dilek Betul Arslan; Hakan Gurvit; Ozan Genc; Ani Kicik; Kardelen Eryurek; Sevim Cengiz; Emel Erdogdu; Zerrin Yildirim; Zeynep Tufekcioglu; Aziz Müfit Uluğ; Basar Bilgic; Hasmet Hanagasi; Erdem Tuzun; Tamer Demiralp; Esin Ozturk-Isik
Journal:  J Neural Transm (Vienna)       Date:  2020-07-06       Impact factor: 3.575

Review 3.  Cognitive decline in Parkinson disease.

Authors:  Dag Aarsland; Byron Creese; Marios Politis; K Ray Chaudhuri; Dominic H Ffytche; Daniel Weintraub; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2017-03-03       Impact factor: 42.937

4.  Quantitative assessment of cerebral venous blood T2 in mouse at 11.7T: Implementation, optimization, and age effect.

Authors:  Zhiliang Wei; Jiadi Xu; Peiying Liu; Lin Chen; Wenbo Li; Peter van Zijl; Hanzhang Lu
Journal:  Magn Reson Med       Date:  2017-12-21       Impact factor: 4.668

5.  Cerebrovascular Perfusion among Older Adults with and Without Cardiovascular Disease.

Authors:  Bindal Makwana; Ariana Tart-Zelvin; Xiaomeng Xu; John J Gunstad; Denise M Cote; Athena Poppas; Ronald A Cohen; Lawrence H Sweet
Journal:  J Neuroimaging       Date:  2020-07-10       Impact factor: 2.486

6.  Arterial spin labelling detects posterior cortical hypoperfusion in non-demented patients with Parkinson's disease.

Authors:  Zoe Joanna Syrimi; Lubomir Vojtisek; Ilona Eliasova; Jana Viskova; Alena Svatkova; Jiri Vanicek; Irena Rektorova
Journal:  J Neural Transm (Vienna)       Date:  2017-03-07       Impact factor: 3.575

Review 7.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

Review 8.  Role of Microvascular Disruption in Brain Damage from Traumatic Brain Injury.

Authors:  Aric F Logsdon; Brandon P Lucke-Wold; Ryan C Turner; Jason D Huber; Charles L Rosen; James W Simpkins
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

9.  Reduced cerebellar gray matter is a neural signature of physical frailty.

Authors:  Wei-Ta Chen; Kun-Hsien Chou; Li-Kuo Liu; Pei-Lin Lee; Wei-Ju Lee; Liang-Kung Chen; Pei-Ning Wang; Ching-Po Lin
Journal:  Hum Brain Mapp       Date:  2015-06-19       Impact factor: 5.038

10.  Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study.

Authors:  Bryan J Neth; Akiva Mintz; Christopher Whitlow; Youngkyoo Jung; Kiran Solingapuram Sai; Thomas C Register; Derek Kellar; Samuel N Lockhart; Siobhan Hoscheidt; Joseph Maldjian; Amanda J Heslegrave; Kaj Blennow; Stephen C Cunnane; Christian-Alexandre Castellano; Henrik Zetterberg; Suzanne Craft
Journal:  Neurobiol Aging       Date:  2019-09-26       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.